Findings

What do systematic reviews say?

9 questions · 10 findings · 2 reviews · Kidney and Transplant · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 5 · 50%Moderate 5 · 50%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Direct match · question page
- Scheduled surveillance vs clinical monitoring alone · Risk of access loss
  Pre‐emptive correction for haemodialysis arteriovenous access stenosis 2016 · Cochrane Headline outcomes only
  RR 0.9 [0.71, 1.15]
  6 studies · 662 participants
  Moderate
Direct match · question page
- Scheduled surveillance vs clinical monitoring alone · Risk of access thrombosis
  Pre‐emptive correction for haemodialysis arteriovenous access stenosis 2016 · Cochrane Headline outcomes only
  RR 0.95 [0.8, 1.12]
  8 studies · 697 participants
  Moderate
Direct match · question page
- Scheduled surveillance vs clinical monitoring alone · Mortality
  Pre‐emptive correction for haemodialysis arteriovenous access stenosis 2016 · Cochrane Headline outcomes only
  RR 1.38 [0.9, 2.11]
  5 studies · 586 participants
  Low
Direct match · question page
- Scheduled surveillance vs clinical monitoring alone · Rate of angiograms
  Pre‐emptive correction for haemodialysis arteriovenous access stenosis 2016 · Cochrane Headline outcomes only
  RR 1.78 [1.18, 2.67]
  5 studies · 539 participants
  Low
Related · question page
- Antibiotic prophylaxis vs surveillance or no treatment · Resolution of VUR after 1 to 2 years: unit of analysis (children)
  Interventions for primary vesicoureteric reflux 2019 · Cochrane Headline outcomes only
  RR 1.46 [0.71, 2.99]
  3 studies · 262 participants
  Low

Scheduled surveillance vs clinical monitoring alone

Access thrombosis/vascular complication · people receiving haemodialysis to treat kidney failure and using a functioning AV access for haemodialysis.

Scheduled surveillance showed no clear difference in risk of access thrombosis compared with clinical monitoring alone (moderate certainty).

1 finding from 1 review

Pre‐emptive correction for haemodialysis arteriovenous access stenosis 2016 · Cochrane Headline outcomes only
RR 0.95 [0.8, 1.12]
8 studies · 697 participants
Moderate

Scheduled surveillance vs clinical monitoring alone

Rate of angiograms · people receiving haemodialysis to treat kidney failure and using a functioning AV access for haemodialysis.

Scheduled surveillance may leads to higher rate of angiograms compared with clinical monitoring alone (low certainty).

1 finding from 1 review

Pre‐emptive correction for haemodialysis arteriovenous access stenosis 2016 · Cochrane Headline outcomes only
RR 1.78 [1.18, 2.67]
5 studies · 539 participants
Low

Scheduled surveillance vs clinical monitoring alone

Risk of access loss · people receiving haemodialysis to treat kidney failure and using a functioning AV access for haemodialysis.

Scheduled surveillance showed no clear difference in risk of access loss compared with clinical monitoring alone (moderate certainty).

1 finding from 1 review

Pre‐emptive correction for haemodialysis arteriovenous access stenosis 2016 · Cochrane Headline outcomes only
RR 0.9 [0.71, 1.15]
6 studies · 662 participants
Moderate

Scheduled surveillance vs clinical monitoring alone

All‐cause mortality · people receiving haemodialysis to treat kidney failure and using a functioning AV access for haemodialysis.

Scheduled surveillance showed no clear difference in mortality compared with clinical monitoring alone (low certainty).

1 finding from 1 review

Pre‐emptive correction for haemodialysis arteriovenous access stenosis 2016 · Cochrane Headline outcomes only
RR 1.38 [0.9, 2.11]
5 studies · 586 participants
Low

Antibiotic prophylaxis vs placebo, no treatment or surveillance only

Number of participants with symptomatic UTI · primary VUR

Antibiotic prophylaxis showed no clear difference in symptomatic UTI by 1 to 2 years: antibiotics versus no prophylaxis compared with surveillance or no treatment (low certainty).

2 findings from 1 review

Interventions for primary vesicoureteric reflux 2019 · Cochrane Headline outcomes only
RR 0.77 [0.54, 1.09]
9 studies · 1667 participants
Low
Interventions for primary vesicoureteric reflux 2019 · Cochrane Headline outcomes only
RR 0.85 [0.4, 1.79]
3 studies · 943 participants
Moderate

Antibiotic prophylaxis vs placebo, no treatment or surveillance only

Febrile UTI by 1 to 2 years: antibiotics versus no prophylaxis · primary VUR

Antibiotic prophylaxis showed no clear difference in febrile UTI by 1 to 2 years: antibiotics versus no prophylaxis compared with surveillance or no treatment (low certainty).

1 finding from 1 review

Interventions for primary vesicoureteric reflux 2019 · Cochrane Headline outcomes only
RR 0.83 [0.56, 1.21]
9 studies · 1667 participants
Low

Antibiotic prophylaxis vs placebo, no treatment or surveillance only

Resolution of VUR · primary VUR

Antibiotic prophylaxis showed no clear difference in resolution of VUR after 1 to 2 years: unit of analysis (children) compared with surveillance or no treatment (low certainty).

1 finding from 1 review

Interventions for primary vesicoureteric reflux 2019 · Cochrane Headline outcomes only
RR 1.46 [0.71, 2.99]
3 studies · 262 participants
Low

Antibiotic prophylaxis vs placebo, no treatment or surveillance only

Adverse events · primary VUR

Antibiotic prophylaxis showed no clear difference in adverse events compared with surveillance or no treatment (moderate certainty).

1 finding from 1 review

Interventions for primary vesicoureteric reflux 2019 · Cochrane Headline outcomes only
RR 0.94 [0.81, 1.08]
4 studies · 1056 participants
Moderate

Antibiotic prophylaxis vs placebo, no treatment or surveillance only

Microbial resistance to prophylactic drug: unit of analysis (UTI) · primary VUR

Antibiotic prophylaxis probably leads to higher microbial resistance to prophylactic drug: unit of analysis (UTI) compared with surveillance or no treatment (moderate certainty).

1 finding from 1 review

Interventions for primary vesicoureteric reflux 2019 · Cochrane Headline outcomes only
RR 2.72 [1.85, 4]
6 studies · 259 participants
Moderate